The Incidence of Diabetes Unawareness in Patients Hospitalized Outside Internal Medicine Services and Related Factors

The Incidence of Diabetes Unawareness in Patients Hospitalized Outside Internal Medicine Services and Related Factors: A Multidisciplinary Study for Detecting Undiagnosed Diabetes

Our purpose is to determine the prevalence of undiagnosed diabetes by checking HbA1c in patients hospitalized outside internal medicine services and assess whether or not there is a difference between those without diabetes awareness and those with known diabetes in terms of age, sex, education status, presence of comorbidity and Body Mass Index (BMI).

Study Overview

• Status: Completed
• Conditions: Diabetes; Inpatient Facililty Diagnoses; Hba1c
• Intervention / Treatment: Diagnostic test: HbA1c

Detailed Description

The study included 630 patients hospitalized outside internal medicine services and internal medicine side-branch services at or over the age of 18 whose anthropometric measurements could be made. The sociodemographic properties and comorbidities of the patients were recorded. Their anthropometric measurements, fasting blood glucose and HbA1c measurements were made. Those with a previous diagnosis of diabetes were grouped as 'Known Diabetes', those without a known diabetes diagnosis but with an HbA1c value of ≥6.5% during hospitalization were grouped as 'Diabetes Unaware', and those with an HbA1C value of <6.5% were grouped as 'No Diabetes'. Whether or not there were differences among the 3 groups based on sociodemographic characteristics, anthropometric measurements and disease statuses was examined.

• Study Type: Observational
• Enrollment (Actual): 630

Contacts and Locations

Study Locations

• Turkey
  • Istanbul, Turkey, 34660
    • Sultan Abdülhamid Han Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The study was conducted at two different tertiary healthcare institutions located in Istanbul in Turkey. Patientswho were inpatients of units other than internal medicine services and internal medicine side-branch services at or over the age of 18 whose anthropometric measurements could be made were included. . The internal units included neurology, dermatology, physiotherapy and rehabilitation, cardiology, infectious diseases and pulmonology services, while the surgical units included general surgery, cardiovascular surgery, pulmonary surgery, orthopedics and traumatology, brain surgery, ophthalmology, urology, gynecology and plastic surgery services.

Description

Inclusion Criteria:

• Inpatients of units other than internal medicine services and internal medicine side-branch services at or
• Over the age of 18
• Anthropometric measurements could be made were included

Exclusion Criteria:

• Had comorbidities that could affect their anthropometric measurements (heart failure, edema, liver cirrhosis, cancer, cachexia, Cushing syndrome, etc.),
• Who had been using steroids for more than a month,
• Pregnant
• Postoperative period

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Inpatients; Patients who were inpatients of units other than internal medicine services and internal medicine side-branch services	Diagnostic test: HbA1c; The participants' age, sex, education level, known diseases, unit of hospitalization and inpatient diagnosis were questioned and recorded. Height, weight and waist circumference measurements were taken. Fasting blood sugar and HbA1c measurements were made; Other Names: Glucose; Anthropometric measures

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Diabetes Unawaraness Prevalance	Diabetes unawaraness prevalance in inpatient settings	14 days

Collaborators and Investigators

• Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Study record dates

Study Major Dates

• Study Start (Actual): April 20, 2017
• Primary Completion (Actual): December 31, 2017
• Study Completion (Actual): December 31, 2017

Study Registration Dates

• First Submitted: January 1, 2021
• First Submitted That Met QC Criteria: January 2, 2021
• First Posted (Actual): January 5, 2021

Study Record Updates

• Last Update Posted (Actual): March 5, 2021
• Last Update Submitted That Met QC Criteria: March 4, 2021
• Last Verified: January 1, 2021

More Information

Terms related to this study

• Keywords: HbA1c; Diabetes Mellitus; Diabetes Unawareness; İnpatient
• Additional Relevant MeSH Terms: Glucose Metabolism Disorders; Metabolic Diseases; Nervous System Diseases; Neurologic Manifestations; Neurobehavioral Manifestations; Endocrine System Diseases; Consciousness Disorders; Diabetes Mellitus; Unconsciousness
• Other Study ID Numbers: INPATİENTA1C

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No